Exscientia | Investor Presentation Deck

Slide schematic 5/5

list 3/3 title 2/2

Components 5

bullet bullet bullet action-title headline

Tools 1

Problem-Agitate-Solve (PAS) slide · 70%

The slide presents a problem (UGT1A1 inhibition), agitates it by highlighting potential negative consequences, and then implies a solution by presenting '565 as an alternative with potential competitive differentiation.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

causal-chain 80%

The slide maps the biological pathway of bilirubin to the clinical consequences of UGT1A1 inhibition.

Find anything

The slide uses a biological mechanism argument to establish a safety/efficacy advantage for the drug candidate '565.